This report contains market size and forecasts of Oncology (Anti-cancer Drugs) in global, including the following market information:
Global Oncology (Anti-cancer Drugs) Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Oncology (Anti-cancer Drugs) Market Sales, 2016-2021, 2022-2027, (K MT)
Global top five Oncology (Anti-cancer Drugs) companies in 2020 (%)
The global Oncology (Anti-cancer Drugs) market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Oncology (Anti-cancer Drugs) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology (Anti-cancer Drugs) Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Oncology (Anti-cancer Drugs) Market Segment Percentages, By Type, 2020 (%)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Others
Global Oncology (Anti-cancer Drugs) Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Oncology (Anti-cancer Drugs) Market Segment Percentages, By Application, 2020 (%)
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Global Oncology (Anti-cancer Drugs) Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K MT)
Global Oncology (Anti-cancer Drugs) Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology (Anti-cancer Drugs) revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Oncology (Anti-cancer Drugs) revenues share in global market, 2020 (%)
Key companies Oncology (Anti-cancer Drugs) sales in global market, 2016-2021 (Estimated), (K MT)
Key companies Oncology (Anti-cancer Drugs) sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Oncology (Anti-cancer Drugs) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology (Anti-cancer Drugs) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology (Anti-cancer Drugs) Overall Market Size
2.1 Global Oncology (Anti-cancer Drugs) Market Size: 2021 VS 2027
2.2 Global Oncology (Anti-cancer Drugs) Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Oncology (Anti-cancer Drugs) Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Oncology (Anti-cancer Drugs) Players in Global Market
3.2 Top Global Oncology (Anti-cancer Drugs) Companies Ranked by Revenue
3.3 Global Oncology (Anti-cancer Drugs) Revenue by Companies
3.4 Global Oncology (Anti-cancer Drugs) Sales by Companies
3.5 Global Oncology (Anti-cancer Drugs) Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Oncology (Anti-cancer Drugs) Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Oncology (Anti-cancer Drugs) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology (Anti-cancer Drugs) Players in Global Market
3.8.1 List of Global Tier 1 Oncology (Anti-cancer Drugs) Companies
3.8.2 List of Global Tier 2 and Tier 3 Oncology (Anti-cancer Drugs) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology (Anti-cancer Drugs) Market Size Markets, 2021 & 2027
4.1.2 Blood Cancer
4.1.3 Breast Cancer
4.1.4 Gastrointestinal Cancer
4.1.5 Prostate Cancer
4.1.6 Others
4.2 By Type - Global Oncology (Anti-cancer Drugs) Revenue & Forecasts
4.2.1 By Type - Global Oncology (Anti-cancer Drugs) Revenue, 2016-2021
4.2.2 By Type - Global Oncology (Anti-cancer Drugs) Revenue, 2022-2027
4.2.3 By Type - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
4.3 By Type - Global Oncology (Anti-cancer Drugs) Sales & Forecasts
4.3.1 By Type - Global Oncology (Anti-cancer Drugs) Sales, 2016-2021
4.3.2 By Type - Global Oncology (Anti-cancer Drugs) Sales, 2022-2027
4.3.3 By Type - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
4.4 By Type - Global Oncology (Anti-cancer Drugs) Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology (Anti-cancer Drugs) Market Size, 2021 & 2027
5.1.2 Chemotherapy
5.1.3 Targeted Therapy
5.1.4 Immunotherapy (Biologic Therapy)
5.1.5 Hormonal Therapy
5.1.6 Others
5.2 By Application - Global Oncology (Anti-cancer Drugs) Revenue & Forecasts
5.2.1 By Application - Global Oncology (Anti-cancer Drugs) Revenue, 2016-2021
5.2.2 By Application - Global Oncology (Anti-cancer Drugs) Revenue, 2022-2027
5.2.3 By Application - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
5.3 By Application - Global Oncology (Anti-cancer Drugs) Sales & Forecasts
5.3.1 By Application - Global Oncology (Anti-cancer Drugs) Sales, 2016-2021
5.3.2 By Application - Global Oncology (Anti-cancer Drugs) Sales, 2022-2027
5.3.3 By Application - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
5.4 By Application - Global Oncology (Anti-cancer Drugs) Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Oncology (Anti-cancer Drugs) Market Size, 2021 & 2027
6.2 By Region - Global Oncology (Anti-cancer Drugs) Revenue & Forecasts
6.2.1 By Region - Global Oncology (Anti-cancer Drugs) Revenue, 2016-2021
6.2.2 By Region - Global Oncology (Anti-cancer Drugs) Revenue, 2022-2027
6.2.3 By Region - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
6.3 By Region - Global Oncology (Anti-cancer Drugs) Sales & Forecasts
6.3.1 By Region - Global Oncology (Anti-cancer Drugs) Sales, 2016-2021
6.3.2 By Region - Global Oncology (Anti-cancer Drugs) Sales, 2022-2027
6.3.3 By Region - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Oncology (Anti-cancer Drugs) Revenue, 2016-2027
6.4.2 By Country - North America Oncology (Anti-cancer Drugs) Sales, 2016-2027
6.4.3 US Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.4.4 Canada Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.4.5 Mexico Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Oncology (Anti-cancer Drugs) Revenue, 2016-2027
6.5.2 By Country - Europe Oncology (Anti-cancer Drugs) Sales, 2016-2027
6.5.3 Germany Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.5.4 France Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.5.5 U.K. Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.5.6 Italy Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.5.7 Russia Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.5.8 Nordic Countries Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.5.9 Benelux Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Oncology (Anti-cancer Drugs) Revenue, 2016-2027
6.6.2 By Region - Asia Oncology (Anti-cancer Drugs) Sales, 2016-2027
6.6.3 China Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.6.4 Japan Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.6.5 South Korea Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.6.6 Southeast Asia Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.6.7 India Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Oncology (Anti-cancer Drugs) Revenue, 2016-2027
6.7.2 By Country - South America Oncology (Anti-cancer Drugs) Sales, 2016-2027
6.7.3 Brazil Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.7.4 Argentina Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Sales, 2016-2027
6.8.3 Turkey Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.8.4 Israel Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.8.5 Saudi Arabia Oncology (Anti-cancer Drugs) Market Size, 2016-2027
6.8.6 UAE Oncology (Anti-cancer Drugs) Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Oncology (Anti-cancer Drugs) Major Product Offerings
7.1.4 Roche Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Novartis
7.2.1 Novartis Corporate Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Oncology (Anti-cancer Drugs) Major Product Offerings
7.2.4 Novartis Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.2.5 Novartis Key News
7.3 Celgene
7.3.1 Celgene Corporate Summary
7.3.2 Celgene Business Overview
7.3.3 Celgene Oncology (Anti-cancer Drugs) Major Product Offerings
7.3.4 Celgene Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.3.5 Celgene Key News
7.4 Amgen
7.4.1 Amgen Corporate Summary
7.4.2 Amgen Business Overview
7.4.3 Amgen Oncology (Anti-cancer Drugs) Major Product Offerings
7.4.4 Amgen Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.4.5 Amgen Key News
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Corporate Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Major Product Offerings
7.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.5.5 Johnson & Johnson Key News
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Corporate Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Major Product Offerings
7.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.6.5 GlaxoSmithKline Key News
7.7 Eli lilly & Co
7.7.1 Eli lilly & Co Corporate Summary
7.7.2 Eli lilly & Co Business Overview
7.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Major Product Offerings
7.4.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.7.5 Eli lilly & Co Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oncology (Anti-cancer Drugs) Major Product Offerings
7.8.4 Pfizer Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.8.5 Pfizer Key News
7.9 Merck & Co.
7.9.1 Merck & Co. Corporate Summary
7.9.2 Merck & Co. Business Overview
7.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Major Product Offerings
7.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.9.5 Merck & Co. Key News
7.10 Sanofi
7.10.1 Sanofi Corporate Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Oncology (Anti-cancer Drugs) Major Product Offerings
7.10.4 Sanofi Oncology (Anti-cancer Drugs) Sales and Revenue in Global (2016-2021)
7.10.5 Sanofi Key News
8 Global Oncology (Anti-cancer Drugs) Production Capacity, Analysis
8.1 Global Oncology (Anti-cancer Drugs) Production Capacity, 2016-2027
8.2 Oncology (Anti-cancer Drugs) Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology (Anti-cancer Drugs) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oncology (Anti-cancer Drugs) Supply Chain Analysis
10.1 Oncology (Anti-cancer Drugs) Industry Value Chain
10.2 Oncology (Anti-cancer Drugs) Upstream Market
10.3 Oncology (Anti-cancer Drugs) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oncology (Anti-cancer Drugs) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Oncology (Anti-cancer Drugs) in Global Market
Table 2. Top Oncology (Anti-cancer Drugs) Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Oncology (Anti-cancer Drugs) Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Oncology (Anti-cancer Drugs) Revenue Share by Companies, 2016-2021
Table 5. Global Oncology (Anti-cancer Drugs) Sales by Companies, (K MT), 2016-2021
Table 6. Global Oncology (Anti-cancer Drugs) Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Oncology (Anti-cancer Drugs) Price (2016-2021) & (USD/MT)
Table 8. Global Manufacturers Oncology (Anti-cancer Drugs) Product Type
Table 9. List of Global Tier 1 Oncology (Anti-cancer Drugs) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology (Anti-cancer Drugs) Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2016-2021
Table 15. By Type - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2022-2027
Table 16. By Application - Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2016-2021
Table 20. By Application - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2022-2027
Table 21. By Region - Global Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Oncology (Anti-cancer Drugs) Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2016-2021
Table 25. By Region - Global Oncology (Anti-cancer Drugs) Sales (K MT), 2022-2027
Table 26. By Country - North America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Oncology (Anti-cancer Drugs) Sales, (K MT), 2016-2021
Table 29. By Country - North America Oncology (Anti-cancer Drugs) Sales, (K MT), 2022-2027
Table 30. By Country - Europe Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Oncology (Anti-cancer Drugs) Sales, (K MT), 2016-2021
Table 33. By Country - Europe Oncology (Anti-cancer Drugs) Sales, (K MT), 2022-2027
Table 34. By Region - Asia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Oncology (Anti-cancer Drugs) Sales, (K MT), 2016-2021
Table 37. By Region - Asia Oncology (Anti-cancer Drugs) Sales, (K MT), 2022-2027
Table 38. By Country - South America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Oncology (Anti-cancer Drugs) Sales, (K MT), 2016-2021
Table 41. By Country - South America Oncology (Anti-cancer Drugs) Sales, (K MT), 2022-2027
Table 42. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Sales, (K MT), 2016-2021
Table 45. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Sales, (K MT), 2022-2027
Table 46. Roche Corporate Summary
Table 47. Roche Oncology (Anti-cancer Drugs) Product Offerings
Table 48. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 49. Novartis Corporate Summary
Table 50. Novartis Oncology (Anti-cancer Drugs) Product Offerings
Table 51. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 52. Celgene Corporate Summary
Table 53. Celgene Oncology (Anti-cancer Drugs) Product Offerings
Table 54. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 55. Amgen Corporate Summary
Table 56. Amgen Oncology (Anti-cancer Drugs) Product Offerings
Table 57. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 58. Johnson & Johnson Corporate Summary
Table 59. Johnson & Johnson Oncology (Anti-cancer Drugs) Product Offerings
Table 60. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 61. GlaxoSmithKline Corporate Summary
Table 62. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product Offerings
Table 63. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 64. Eli lilly & Co Corporate Summary
Table 65. Eli lilly & Co Oncology (Anti-cancer Drugs) Product Offerings
Table 66. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer Oncology (Anti-cancer Drugs) Product Offerings
Table 69. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 70. Merck & Co. Corporate Summary
Table 71. Merck & Co. Oncology (Anti-cancer Drugs) Product Offerings
Table 72. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 73. Sanofi Corporate Summary
Table 74. Sanofi Oncology (Anti-cancer Drugs) Product Offerings
Table 75. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2016-2021)
Table 76. Oncology (Anti-cancer Drugs) Production Capacity (K MT) of Key Manufacturers in Global Market, 2019-2021 (K MT)
Table 77. Global Oncology (Anti-cancer Drugs) Capacity Market Share of Key Manufacturers, 2019-2021
Table 78. Global Oncology (Anti-cancer Drugs) Production by Region, 2016-2021 (K MT)
Table 79. Global Oncology (Anti-cancer Drugs) Production by Region, 2022-2027 (K MT)
Table 80. Oncology (Anti-cancer Drugs) Market Opportunities & Trends in Global Market
Table 81. Oncology (Anti-cancer Drugs) Market Drivers in Global Market
Table 82. Oncology (Anti-cancer Drugs) Market Restraints in Global Market
Table 83. Oncology (Anti-cancer Drugs) Raw Materials
Table 84. Oncology (Anti-cancer Drugs) Raw Materials Suppliers in Global Market
Table 85. Typical Oncology (Anti-cancer Drugs) Downstream
Table 86. Oncology (Anti-cancer Drugs) Downstream Clients in Global Market
Table 87. Oncology (Anti-cancer Drugs) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oncology (Anti-cancer Drugs) Segment by Type
Figure 2. Oncology (Anti-cancer Drugs) Segment by Application
Figure 3. Global Oncology (Anti-cancer Drugs) Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oncology (Anti-cancer Drugs) Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oncology (Anti-cancer Drugs) Revenue, 2016-2027 (US$, Mn)
Figure 7. Oncology (Anti-cancer Drugs) Sales in Global Market: 2016-2027 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Oncology (Anti-cancer Drugs) Revenue in 2020
Figure 9. By Type - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 10. By Type - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 11. By Type - Global Oncology (Anti-cancer Drugs) Price (USD/MT), 2016-2027
Figure 12. By Application - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 13. By Application - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 14. By Application - Global Oncology (Anti-cancer Drugs) Price (USD/MT), 2016-2027
Figure 15. By Region - Global Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 16. By Region - Global Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 17. By Country - North America Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 18. By Country - North America Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 19. US Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 24. Germany Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 25. France Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 33. China Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 37. India Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 39. By Country - South America Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 40. Brazil Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Oncology (Anti-cancer Drugs) Sales Market Share, 2016-2027
Figure 44. Turkey Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Oncology (Anti-cancer Drugs) Revenue, (US$, Mn), 2016-2027
Figure 48. Global Oncology (Anti-cancer Drugs) Production Capacity (K MT), 2016-2027
Figure 49. The Percentage of Production Oncology (Anti-cancer Drugs) by Region, 2020 VS 2027
Figure 50. Oncology (Anti-cancer Drugs) Industry Value Chain
Figure 51. Marketing Channels
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi